Search - tctmd.com

Displaying 481 - 500 of 3107

Sort: Relevancy | Date

Presentation NY Valves 2024

Treatment of Arteriovenous Fistula-Induced Tricuspid Regurgitation With VDyne Transcatheter Tricuspid Valve Device

Presenter: Nicholas Stephen Amoroso

June 05, 2024

Presentation NY Valves 2024

Outcomes Following Transcatheter Mitral Valve Replacement Using Dedicated Devices in Patients With Mitral Annular Calcification

Presenter: Augustin Coisne

June 05, 2024

Presentation NY Valves 2024

The Promise of Next Generation Cerebral Embolic Protection Devices

Presenter: Tamim M. Nazif

June 05, 2024

Presentation NY Valves 2024

LAAO Unraveled: Filamentous Material Extruded From Amplatzer™ Delivery Sheath During Attempted Delivery of Amulet™ Device

Presenter: Anastasia Malek

June 05, 2024

Presentation NY Valves 2024

A Comprehensive Linked Registry for the Post-Market Evaluation of Cardiovascular Devices: Rationale and Design of the Massachusetts Cardiovascular [MassCar] Registry

Presenter: Zaid I. Almarzooq

June 05, 2024

Presentation NY Valves 2024

Modern Era Clinical Trial Strategies For Cerebral Embolic Protection Devices

Presenter: Alexandra J. Lansky

June 05, 2024

Presentation NY Valves 2024

Transcatheter Amplatzer Vascular Plug to Treat Peri-Device Leak After Left Atrial Appendage (LAAO) Closure

Presenter: Saurabh Gupta

June 05, 2024

Presentation NY Valves 2024

M-TEER Beyond the Yellow Zone: Patient and Device Selection

Presenter: D. Scott Lim

June 05, 2024

Presentation NY Valves 2024

Using Multiflex Steerable Sheath for Left Atrial Appendage Closure Device Retrieval

Presenter: Noel Maldonado

June 05, 2024

Presentation NY Valves 2024

Patient and Device Selection Following Commercial Approval of TTVI Devices: European Perspectives

Presenter: Jörg Hausleiter

June 05, 2024

Presentation NY Valves 2024

Transcatheter Retrieval of Malpositioned Left Atrial Appendage Closure Device

Presenter: Akshay Kamath

June 05, 2024

Presentation NY Valves 2024

Impact of Cerebral Embolic Protection Devices on Disabling Stroke After Transcatheter Aortic Valve Replacement: Results From the STS/ACC TVT Registry

Presenter: Neel Butala

June 05, 2024

Presentation NY Valves 2024

A Novel AI-Powered Non-Invasive Screening Device for Aortic Stenosis (Clearsight)

Presenter: Joseph Kassab

June 05, 2024

Presentation NY Valves 2024

Lifetime Management of Transcatheter Tricuspid Valve Replacement: Patient and Device Considerations

Presenter: Gabriel Sayer

June 05, 2024

Presentation NY Valves 2024

Case Presentation: M-TEER in Commissural Disease: Device Selection and Procedural Considerations

Presenter: Sam Dawkins

June 05, 2024

Presentation NY Valves 2024

Case Presentation: M-TEER in a Small Left Atrium: Device Selection and Procedural Considerations

Presenter: Tom Cahill

June 05, 2024

Presentation NY Valves 2024

Case Presentation: Unraveling Post-M-TEER Gradients: Evaluating Risk of Mitral Stenosis

Presenter: Masahiko Asami

June 05, 2024

Presentation NY Valves 2024

Defining Technical Success Post-M-TEER: MR Reduction and Hemodynamics

Presenter: Amar Krishnaswamy

June 05, 2024

Presentation EuroPCR 2024

Early outcomes of a randomised non-inferiority trial comparing TAVI devices: the LANDMARK trial

Presenter: Patrick Serruys

May 15, 2024

Presentation EuroPCR 2024

First report of an IDE pivotal study of a dedicated splitting device during TAVR

Presenter: Danny Dvir

May 15, 2024

Advertisement

Treatment of Arteriovenous Fistula-Induced Tricuspid Regurgitation With VDyne Transcatheter Tricuspid Valve Device

Outcomes Following Transcatheter Mitral Valve Replacement Using Dedicated Devices in Patients With Mitral Annular Calcification

The Promise of Next Generation Cerebral Embolic Protection Devices

LAAO Unraveled: Filamentous Material Extruded From Amplatzer™ Delivery Sheath During Attempted Delivery of Amulet™ Device

A Comprehensive Linked Registry for the Post-Market Evaluation of Cardiovascular Devices: Rationale and Design of the Massachusetts Cardiovascular [MassCar] Registry

Modern Era Clinical Trial Strategies For Cerebral Embolic Protection Devices

Transcatheter Amplatzer Vascular Plug to Treat Peri-Device Leak After Left Atrial Appendage (LAAO) Closure

M-TEER Beyond the Yellow Zone: Patient and Device Selection

Using Multiflex Steerable Sheath for Left Atrial Appendage Closure Device Retrieval

Patient and Device Selection Following Commercial Approval of TTVI Devices: European Perspectives

Transcatheter Retrieval of Malpositioned Left Atrial Appendage Closure Device

Impact of Cerebral Embolic Protection Devices on Disabling Stroke After Transcatheter Aortic Valve Replacement: Results From the STS/ACC TVT Registry

A Novel AI-Powered Non-Invasive Screening Device for Aortic Stenosis (Clearsight)

Lifetime Management of Transcatheter Tricuspid Valve Replacement: Patient and Device Considerations

Case Presentation: M-TEER in Commissural Disease: Device Selection and Procedural Considerations

Case Presentation: M-TEER in a Small Left Atrium: Device Selection and Procedural Considerations

Case Presentation: Unraveling Post-M-TEER Gradients: Evaluating Risk of Mitral Stenosis

Defining Technical Success Post-M-TEER: MR Reduction and Hemodynamics

Early outcomes of a randomised non-inferiority trial comparing TAVI devices: the LANDMARK trial

First report of an IDE pivotal study of a dedicated splitting device during TAVR

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content